Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance
WEBGet the latest Pfizer Inc. (PFE) stock news and headlines to help you in your trading and investing decisions.
Press Releases - Pfizer
WEB5 days ago · Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. 09.11.2024. Research and Pipeline.
Newsroom - Pfizer
WEB5 days ago · Updates and Statements. Pfizer Receives Positive CHMP Opinion for its Treatment for Adults and Adolescents with Hemophilia A and B. Pfizer Statement on Publication of ELIQUIS® Maximum Fair Price. View All Updates and Statements.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
Pfizer’s gene therapy for rare genetic bleeding disorder ... - CNBC
WEBJul 24, 2024 · Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for ...
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
WEBMay 22, 2024 · U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last...
Pfizer Is Rising Past Covid-19 - Yahoo Finance
WEB1 day ago · Pfizer's pandemic-fueled revenue surge, largely driven by Covid-19 products like Comirnaty, has now become a challenge as vaccine revenues sharply decline. In the second quarter, Comirnaty sales ...
Pfizer pins hopes on record pipeline to recover from post-Covid …
WEBFeb 21, 2023 · Pfizer expects sales of Comirnaty, the Covid vaccine it developed with German company BioNTech, and its antiviral pill Paxlovid, to fall 62 per cent to $21.5bn in 2023, compared to last year.
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
WEBJan 13, 2023 · The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to ...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …
WEBJun 25, 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron Geometric mean ratios for Omicron neutralizing antibody …
- Some results have been removed